ES3038403T3 - Implantable device with intravesical tolerability - Google Patents

Implantable device with intravesical tolerability

Info

Publication number
ES3038403T3
ES3038403T3 ES21157457T ES21157457T ES3038403T3 ES 3038403 T3 ES3038403 T3 ES 3038403T3 ES 21157457 T ES21157457 T ES 21157457T ES 21157457 T ES21157457 T ES 21157457T ES 3038403 T3 ES3038403 T3 ES 3038403T3
Authority
ES
Spain
Prior art keywords
drug
bladder
approximately
lumen
retention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES21157457T
Other languages
English (en)
Spanish (es)
Inventor
Michael Cima
Heejin Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taris Biomedical LLC
Original Assignee
Taris Biomedical LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical LLC filed Critical Taris Biomedical LLC
Application granted granted Critical
Publication of ES3038403T3 publication Critical patent/ES3038403T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/042—Urinary bladders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
ES21157457T 2009-12-17 2010-12-17 Implantable device with intravesical tolerability Active ES3038403T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28764909P 2009-12-17 2009-12-17
US32571310P 2010-04-19 2010-04-19

Publications (1)

Publication Number Publication Date
ES3038403T3 true ES3038403T3 (en) 2025-10-13

Family

ID=43769298

Family Applications (2)

Application Number Title Priority Date Filing Date
ES21157457T Active ES3038403T3 (en) 2009-12-17 2010-12-17 Implantable device with intravesical tolerability
ES10801519T Active ES2867399T3 (es) 2009-12-17 2010-12-17 Dispositivo implantable con tolerabilidad intravesical

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES10801519T Active ES2867399T3 (es) 2009-12-17 2010-12-17 Dispositivo implantable con tolerabilidad intravesical

Country Status (18)

Country Link
US (4) US8679094B2 (cg-RX-API-DMAC7.html)
EP (2) EP2512581B1 (cg-RX-API-DMAC7.html)
JP (3) JP2013514837A (cg-RX-API-DMAC7.html)
AU (1) AU2010339821B2 (cg-RX-API-DMAC7.html)
CA (1) CA2784601C (cg-RX-API-DMAC7.html)
CY (1) CY1124354T1 (cg-RX-API-DMAC7.html)
DK (2) DK3884988T3 (cg-RX-API-DMAC7.html)
ES (2) ES3038403T3 (cg-RX-API-DMAC7.html)
FI (1) FI3884988T3 (cg-RX-API-DMAC7.html)
HR (2) HRP20250946T1 (cg-RX-API-DMAC7.html)
HU (2) HUE053888T2 (cg-RX-API-DMAC7.html)
LT (2) LT2512581T (cg-RX-API-DMAC7.html)
PL (2) PL2512581T3 (cg-RX-API-DMAC7.html)
PT (2) PT3884988T (cg-RX-API-DMAC7.html)
RS (2) RS61980B1 (cg-RX-API-DMAC7.html)
SI (2) SI2512581T1 (cg-RX-API-DMAC7.html)
SM (2) SMT202500293T1 (cg-RX-API-DMAC7.html)
WO (1) WO2011084712A1 (cg-RX-API-DMAC7.html)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US8603106B2 (en) 2005-05-20 2013-12-10 Neotract, Inc. Integrated handle assembly for anchor delivery system
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US8628542B2 (en) 2005-05-20 2014-01-14 Neotract, Inc. Median lobe destruction apparatus and method
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8668705B2 (en) 2005-05-20 2014-03-11 Neotract, Inc. Latching anchor device
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
EP2512581B1 (en) * 2009-12-17 2021-02-17 TARIS Biomedical LLC Implantable device with intravesical tolerability
WO2016191479A1 (en) * 2015-05-26 2016-12-01 Taris Biomedical Llc Urodynamic assessment systems and methods
US20110218488A1 (en) * 2010-03-05 2011-09-08 Taris Biomedical, Inc. Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
US20110308835A1 (en) * 2010-06-16 2011-12-22 Piekny Mark G Self-coiling apparatus
LT2600800T (lt) 2010-08-05 2021-01-11 Taris Biomedical Llc Ureteralinio stento pavidalo vaisto vartojimo įtaisas ir rinkinys
WO2012048104A1 (en) 2010-10-06 2012-04-12 Taris Biomedical, Inc. Implantable drug delivery device with bladden retention feature
JP5945544B2 (ja) 2010-10-06 2016-07-05 タリス バイオメディカル エルエルシー 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法
US8679093B2 (en) 2010-11-23 2014-03-25 Microchips, Inc. Multi-dose drug delivery device and method
AU2012205654B2 (en) 2011-01-10 2016-09-08 Allergan, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US9883906B2 (en) 2012-04-22 2018-02-06 Newuro, B.V. Bladder tissue modification for overactive bladder disorders
US10610294B2 (en) 2012-04-22 2020-04-07 Newuro, B.V. Devices and methods for transurethral bladder partitioning
US9387163B2 (en) * 2012-04-30 2016-07-12 Allergan, Inc. Methods for treatment of pelvic pain and/or comorbid conditions
WO2013177068A1 (en) * 2012-05-19 2013-11-28 Taris Biomedical, Inc. Implantable urological device with improved retrieval feature
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
CA2882575C (en) 2012-08-31 2020-05-26 Dennis GIESING Drug delivery systems and methods for treatment of prostate
LT2890384T (lt) 2012-08-31 2022-01-10 Taris Biomedical Llc Vaistų pateikimo sistemos ir kraujo vėžio gydymo būdai, apimantys oksaliplatiną
KR102141433B1 (ko) * 2012-09-18 2020-08-05 타리스 바이오메디컬 엘엘씨 트로스피움을 이용함으로써 방광 배뇨 장애 및 다른 하부 요도관 장애의 치료를 위한 약물 전달 시스템과 방법
WO2014138214A1 (en) 2013-03-05 2014-09-12 Taris Biomedical, Inc. Drug delivery devices and methods for controlled drug release through device orifice
CN105209012B (zh) 2013-03-15 2019-02-01 塔里斯生物医药公司 用于药物递送的药物递送装置和方法
BR112015022433B1 (pt) 2013-03-15 2022-06-21 Taris Biomedical Llc Dispositivo de liberação de droga intravesical
HRP20201421T1 (hr) 2013-08-19 2020-12-11 Taris Biomedical Llc Uređaji za davanje više jedinica lijeka
RU2016120199A (ru) 2013-11-05 2017-12-11 ТАРИС Биомедикал ЛЛК Осмотические устройства, комплекты и способы для доставки лекарственных средств
LT3113782T (lt) * 2014-03-06 2022-11-25 Taris Biomedical Llc Vaisto tiekimo sistemos ir būdai, skirti šlapimo pūslės vėžio gydymui gemcitabinu
US10933170B2 (en) 2014-05-12 2021-03-02 Taris Biomedical Llc Drug delivery devices and methods
AU2015279674B2 (en) * 2014-06-26 2020-07-23 Taris Biomedical Llc Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
US20170246437A1 (en) 2014-09-12 2017-08-31 Taris Biomedical Llc pH-MODULATING DRUG DELIVERY DEVICES AND METHODS
JP6743041B2 (ja) 2015-03-30 2020-08-19 タリス バイオメディカル エルエルシー 上部尿路への薬剤の局所的な送達装置及び方法
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
US10159850B2 (en) 2016-01-06 2018-12-25 Covidien Lp Brachytherapy clip and applicator
WO2017132372A1 (en) 2016-01-26 2017-08-03 Taris Biomedical Llc Multi-lumen drug delivery devices
WO2017151983A1 (en) 2016-03-02 2017-09-08 Taris Biomedical Llc Osmotic drug delivery devices and methods of making osmotic drug delivery devices
MX389296B (es) 2016-05-06 2025-03-20 Taris Biomedical Llc Metodo para tratar cancer urotelial del tracto inferior.
US11707611B2 (en) * 2016-11-08 2023-07-25 W. L. Gore & Associates, Inc. Implantable apparatus for retention of biological moieties
AU2017371223B2 (en) 2016-12-09 2023-04-27 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
SI3432970T1 (sl) 2017-02-01 2021-11-30 Taris Biomedical Llc Naprave za dovajanje zdravila IN VIVO
CA3071014A1 (en) 2017-07-25 2019-01-31 Taris Biomedical Llc Methods of treating tumor metastasis
CN111432807A (zh) 2017-10-06 2020-07-17 铸造疗法股份有限公司 用于控制释放治疗剂的可植入贮库
JOP20200124A1 (ar) 2017-11-08 2020-05-20 Taris Biomedical Llc طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك
SG11202005766XA (en) 2017-12-23 2020-07-29 Neotract Inc Expandable tissue engagement apparatus and method
CN111655303A (zh) 2018-01-08 2020-09-11 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
CN112367980A (zh) 2018-05-12 2021-02-12 铸造疗法股份有限公司 用于控制释放治疗剂的可植入贮库
CA3107461A1 (en) 2018-08-01 2020-02-06 Taris Biomedical Llc Methods of treating overactive bladder using trospium
WO2020047013A1 (en) 2018-08-28 2020-03-05 Foundry Therapeutics, Inc. Polymer implants
US12440301B2 (en) 2018-11-07 2025-10-14 Teleflex Life Sciences Llc System for delivery of a fiducial marker
MX2024004488A (es) 2021-10-12 2024-07-10 Taris Biomedical Llc Formulaciones y sistemas de erdafitinib para administración intravesical.
AU2022418527A1 (en) 2021-12-21 2024-08-08 Taris Biomedical Llc Urinary placement catheter for intravesical devices
CN119072311A (zh) 2022-02-18 2024-12-03 塔里斯生物医药公司 用于膀胱内施用的厄达替尼制剂和渗透系统
US12426818B2 (en) 2022-06-08 2025-09-30 Bright Uro, Inc. Packaging assembly and method of preparing sensing device for insertion into a body cavity to preserve sterility
AU2023284982A1 (en) 2022-06-08 2025-01-09 Bright Uro, Inc. Systems and methods for urological sensing
EP4536100A1 (en) * 2022-06-10 2025-04-16 Balt Usa, Llc Implants and systems for vascular treatment
WO2024092159A1 (en) 2022-10-28 2024-05-02 Taris Biomedical Llc Methods of treating bladder cancer with gemcitabine
WO2024173377A1 (en) 2023-02-13 2024-08-22 Taris Biomedical Llc Erdafitinib for intravesical administration for use in the treatment of bladder cancer
WO2024173716A1 (en) 2023-02-17 2024-08-22 Taris Biomedical Llc Erdafitinib for intravesical administration for use in the treatment of bladder cancer
WO2024215682A1 (en) 2023-04-10 2024-10-17 Taris Biomedical Llc Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy
CN117017567B (zh) * 2023-08-12 2024-04-09 上海市第一人民医院 一种植入式膀胱收缩系统、工作方法及人造膀胱
WO2025059602A1 (en) 2023-09-14 2025-03-20 Taris Biomedical Llc Methods of treating bladder cancer using intravesical administration of erdafitinib
TW202532086A (zh) 2023-10-02 2025-08-16 美商塔里斯生物醫學有限責任公司 治療對卡介苗療法無反應之高風險非肌肉侵襲性膀胱癌之方法
GB202401392D0 (en) * 2024-02-02 2024-03-20 Imphatec Ltd Implant for delivery of a drug

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3935860A (en) * 1974-08-21 1976-02-03 Alza Corporation Intrauterine device with restrictor for maintaining device in uterine cavity
US4968507A (en) 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US4871542A (en) * 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
NZ244682A (en) * 1991-10-10 1993-12-23 Alza Corp Osmotically driven controlled delivery device characterised in that a
DE69329407T2 (de) 1992-06-02 2001-05-03 Bard Inc C R Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe
US5516522A (en) * 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
US6171298B1 (en) * 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
JP2001519787A (ja) * 1997-04-03 2001-10-23 ポイント バイオメディカル コーポレイション 膀胱内ドラッグデリバリーシステム
US6749617B1 (en) * 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
WO1999042147A1 (en) 1998-02-23 1999-08-26 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6183461B1 (en) * 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
US6159143A (en) * 1998-06-17 2000-12-12 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6293923B1 (en) * 1999-03-15 2001-09-25 Innoventions, Inc. Intravesicular balloon
US7135311B1 (en) * 1999-05-05 2006-11-14 Institut Curie Means for detecting and treating pathologies linked to FGFR3
US6139535A (en) 1999-05-27 2000-10-31 Situs Corporation Method and apparatus for placement and activation of a medical device within a body cavity
JP2003516343A (ja) 1999-12-10 2003-05-13 マサチューセッツ インスティテュート オブ テクノロジー 分子を送達するマイクロチップ素子およびその製作方法
US7470228B2 (en) * 2000-04-14 2008-12-30 Attenuex Technologies, Inc. Method of treating benign hypertrophy of the prostate
US6682473B1 (en) * 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US6749553B2 (en) * 2000-05-18 2004-06-15 Theragenics Corporation Radiation delivery devices and methods for their manufacture
US6398718B1 (en) * 2000-06-15 2002-06-04 Innoventions, Inc. Intravesicular device
EP1427366A2 (en) * 2001-08-29 2004-06-16 UMD, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
WO2003028660A2 (en) * 2001-10-04 2003-04-10 Case Western Reserve University Drug delivery devices and methods
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
GB2385273B (en) * 2002-02-13 2004-05-26 Deborah Huang Drug delivery device
US6949125B2 (en) 2002-04-16 2005-09-27 Boston Scientific Scimed, Inc. Ureteral stent with end-effector and related methods
GB0211286D0 (en) 2002-05-16 2002-06-26 Nokia Corp Routing data packets through a wireless network
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
EP1553899A4 (en) 2002-10-22 2006-10-25 METHOD AND SYSTEM FOR INTRAVASCULAR DELIVERY OF THERAPEUTIC AGENTS
EP1587450A2 (en) 2002-12-16 2005-10-26 The Regents Of The University Of Michigan Assembly and planar structure for use therein which is expandable into a 3-d structure such as a stent and device for making the planar structure
US20050228482A1 (en) * 2003-09-26 2005-10-13 William Herzog Stent covered by a layer having a layer opening
CA2555648A1 (en) 2004-02-11 2005-08-25 Ethicon, Inc. System and method for urodynamic evaluation utilizing micro-electronic mechanical system
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
JP5265359B2 (ja) * 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
US20070255222A1 (en) 2006-03-27 2007-11-01 Changqing Li Catheter assembly including internal bolster
CA2661191C (en) 2006-08-23 2014-12-02 Svip 2 Llc Devices and methods for altering eating behavior
US20100076261A1 (en) * 2006-09-28 2010-03-25 Medvision Inc. Examination device
US8128576B2 (en) 2006-12-07 2012-03-06 Ethicon, Inc. System and method for urodynamic evaluation utilizing micro electro-mechanical system technology
EP2231254B9 (en) 2007-12-11 2015-04-08 Massachusetts Institute of Technology Implantable drug delivery device
WO2009097468A2 (en) * 2008-01-29 2009-08-06 Kliman Gilbert H Drug delivery devices, kits and methods therefor
BRPI0917135A2 (pt) * 2008-08-09 2015-11-10 Massachusetts Inst Technology dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica.
US20100048266A1 (en) 2008-08-19 2010-02-25 Samsung Electronics Co., Ltd. Antenna device
WO2010151896A1 (en) * 2009-06-26 2010-12-29 Taris Biomedical, Inc. Solid drug tablets for implantable drug delivery devices
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
EP2512581B1 (en) * 2009-12-17 2021-02-17 TARIS Biomedical LLC Implantable device with intravesical tolerability

Also Published As

Publication number Publication date
HRP20250946T1 (hr) 2025-10-10
SMT202100236T1 (it) 2021-05-07
US11065426B2 (en) 2021-07-20
SMT202500293T1 (it) 2025-09-12
AU2010339821B2 (en) 2015-02-19
EP3884988A1 (en) 2021-09-29
AU2010339821A1 (en) 2012-07-05
PT3884988T (pt) 2025-09-01
US20240198067A1 (en) 2024-06-20
CY1124354T1 (el) 2022-07-22
SI3884988T1 (sl) 2025-09-30
DK2512581T3 (da) 2021-03-29
PT2512581T (pt) 2021-04-27
JP2013514837A (ja) 2013-05-02
EP2512581A1 (en) 2012-10-24
HRP20210329T1 (hr) 2021-06-25
PL3884988T3 (pl) 2025-09-08
EP3884988B1 (en) 2025-06-18
RS61980B1 (sr) 2021-07-30
DK3884988T3 (da) 2025-08-18
WO2011084712A1 (en) 2011-07-14
US20210252262A1 (en) 2021-08-19
JP2016022392A (ja) 2016-02-08
LT2512581T (lt) 2021-03-25
CA2784601C (en) 2016-06-14
US20140221981A1 (en) 2014-08-07
CA2784601A1 (en) 2011-07-14
RS67130B1 (sr) 2025-09-30
LT3884988T (lt) 2025-08-25
EP2512581B1 (en) 2021-02-17
US20110152839A1 (en) 2011-06-23
HUE053888T2 (hu) 2021-07-28
US8679094B2 (en) 2014-03-25
JP2017189688A (ja) 2017-10-19
ES2867399T3 (es) 2021-10-20
HUE073030T2 (hu) 2025-12-28
JP6247270B2 (ja) 2017-12-13
PL2512581T3 (pl) 2021-11-02
JP6854210B2 (ja) 2021-04-07
SI2512581T1 (sl) 2021-09-30
FI3884988T3 (fi) 2025-08-08
US11890439B2 (en) 2024-02-06

Similar Documents

Publication Publication Date Title
ES3038403T3 (en) Implantable device with intravesical tolerability
JP7455084B2 (ja) 薬物透過性構成部材を備えた薬物送達デバイス、及び方法
ES2832524T3 (es) Dispositivo y kit de administración de fármacos para endoprótesis ureteral
US9457176B2 (en) Implantable drug delivery device with bladder retention feature
US8690840B2 (en) Time-selective bioresorbable or collapsible drug delivery systems and methods
AU2015201123B2 (en) Implantable device with intravesical tolerability and methods of treatment
HK40059299B (en) Implantable device with intravesical tolerability
HK40059299A (en) Implantable device with intravesical tolerability
HK40039856A (en) Ureteral stent drug delivery device
HK40049270A (en) Ureteral stent drug delivery device
HK1186087B (en) Ureteral stent drug delivery device and kit